Clarity Pharmaceuticals (ASX:CU6) Signs Copper-64 Supply Agreement with Nusano
Clarity Pharmaceuticals (ASX:CU6) secures a copper-64 supply agreement with Nusano to support clinical trials and commercialization.
Clarity Pharmaceuticals (ASX:CU6) secures a copper-64 supply agreement with Nusano to support clinical trials and commercialization.
Anatara Lifesciences (ASX:ANR) reports Phase II GaRP-IBS trial results, highlighting safety and significant improvements in anxiety scores.
Dreadnought Resources Ltd (ASX:DRE) closes its Share Purchase Plan, raising $1.73M with strong shareholder support.
Podium Minerals (ASX:POD) completes the EV Nickel acquisition and becomes the first Australian PGM developer to join the World Platinum Investment Council.
Streamplay Studio (ASX:SP8) launches Sacre Bleu globally on Nintendo Switch and Steam, marking its first title on these platforms.
Pilbara Minerals (ASX:PLS) reports March quarter production of 125 kt, reduced revenue, and key project completions.
Mighty Kingdom Limited (ASX:MKL) issues a replacement prospectus for a non-renounceable entitlement offer, aiming to raise up to $1.08M to support operational growth and profitability.
BHP (ASX:BHP) achieves record copper and iron ore production in FY25, showcasing business resilience and strategic growth initiatives.
Challenger Limited (ASX:CGF) reports Q3 revenue growth in annuity sales and maintains strong capitalisation.
Black Cat Syndicate Limited (ASX:BC8) pours first gold at Lakewood, marking a significant milestone in its Kal East gold production plan.